One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Synthetic Biology Market

[ 英語タイトル ] Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022


Product Code : MNMHC00109104
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global synthetic biology market is projected to grow at a CAGR of 19.9%. in the next five years”
The synthetic biology market is expected to reach USD 8.84 billion by 2022 from an estimated USD 3.57 billion in 2017, at a CAGR of 19.9%. The key factors driving the growth of this market include the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. On the other hand, possible environmental and security issues related to synthetic biology are likely to restrain the growth of this market to a certain extent.

“The chassis organisms segment is expected to grow at the highest rate during the forecast period (2017-2022).”
On the basis of tools, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to witness the highest growth during the forecast period due to the increasing research on chassis organisms and the rising global demand of for alternatives to fossil fuel.

“The gene synthesis technology is expected to hold the largest share of the market in 2017
Based on technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. The gene synthesis segment is expected to account for the largest share of the synthetic biology market. This is attributed to the factors such as growth in the energy and agriculture industry; applications in environmental testing; and research in DNA-based vaccines and bioengineered antibodies.

“Pharmaceutical applications are expected to hold the largest share of the synthetic biology market in 2017.”
Based on application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), environmental (bioremediation and biosensing), and food & agriculture applications. The pharmaceuticals subsegment is expected to account for the largest share in the market in 2017. This is attributed to the potential of synthetic biology techniques in the development and manufacturing of APIs and small molecules on a large scale.

“China to witness the highest growth during the forecast period”
While the US is expected to hold the largest share of the global synthetic biology market in 2017, China is expected to witness the highest growth during 2017 to 2022. Rising R&D funding and awareness programs regarding synthetic biology are contributing to the growth of synthetic biology market in China.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–28%, Tier 2–33% and Tier 3–39%
• By Designation – C-level–42%, Director Level–33%, Others–25%
• By Region – North America–41%, Europe–35%, Asia Pacific–14%, RoW–10%

The major players in the global synthetic biology market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US). Some other players in this market include Intrexon Corporation (US), Agilent Technologies (US), Amyris (US), Genescript Biotech Corporation (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).
Research Coverage:
The report analyzes the synthetic biology market and aims at estimating the market size and growth potential of this market based on various aspects such as tools, technologies, applications, and regions. The report also includes a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by key players in the global synthetic biology market. The report analyzes the global synthetic biology market by tool, technology, application, and region.
• Product and Service Innovation: Detailed insights on upcoming trends and new product and service launches in the global synthetic biology market
• Market Development: Comprehensive information about the lucrative emerging markets by tool, technology, application, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global synthetic biology market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products in pipeline of leading players in the global market

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS COVERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY DATA 24
2.1.2.1 Key data from primary sources 24
2.1.2.2 Key industry insights 25
2.2 MARKET SIZE ESTIMATION 26
2.2.1 BOTTOM-UP APPROACH 26
2.2.2 TOP-DOWN APPROACH 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW 35
4.2 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL & COUNTRY 36
4.3 GLOBAL SYNTHETIC BIOLOGY MARKET: GEOGRAPHIC MIX 36
4.4 GLOBAL SYNTHETIC BIOLOGY MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 37
4.5 GLOBAL SYNTHETIC BIOLOGY MARKET: GEOGRAPHIC SNAPSHOT 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Wide range of applications of synthetic biology 39
5.2.1.2 Rising R&D funding and initiatives in synthetic biology 40

5.2.1.3 Increasing demand for synthetic genes and synthetic cells 41
5.2.1.4 Increasing investments in synthetic biology companies 42
5.2.2 RESTRAINTS 43
5.2.2.1 Environmental and security issues 43
5.2.3 OPPORTUNITIES 44
5.2.3.1 Rising concerns related to fuel consumption 44
5.2.3.2 Increasing demand for protein therapeutics 45
5.2.4 CHALLENGES 46
5.2.4.1 Standardization of biological parts 46
6 SYNTHETIC BIOLOGY MARKET, BY TOOL AND TECHNOLOGY 47
6.1 TOOL 48
6.1.1 OLIGONUCLEOTIDES 51
6.1.2 ENZYMES 52
6.1.3 CLONING TECHNOLOGY KITS 53
6.1.4 CHASSIS ORGANISMS 54
6.1.5 XENO-NUCLEIC ACIDS 55
6.2 TECHNOLOGY 56
6.2.1 GENE SYNTHESIS 58
6.2.2 GENOME ENGINEERING 59
6.2.3 CLONING AND SEQUENCING 60
6.2.4 NEXT-GENERATION SEQUENCING 61
6.2.5 SITE-DIRECTED MUTAGENESIS 62
6.2.6 MEASUREMENT AND MODELING 63
6.2.7 MICROFLUIDICS 64
6.2.8 NANOTECHNOLOGY 65
7 SYNTHETIC BIOLOGY MARKET, BY APPLICATION 66
7.1 INTRODUCTION 67
7.2 MEDICAL APPLICATIONS 69
7.2.1 PHARMACEUTICALS 71
7.2.2 DRUG DISCOVERY AND THERAPEUTICS 72
7.2.3 ARTIFICIAL TISSUE AND TISSUE REGENERATION 73
7.3 INDUSTRIAL APPLICATIONS 74
7.3.1 BIOFUEL AND RENEWABLE ENERGY 76
7.3.2 BIOMATERIALS AND GREEN CHEMICALS 77
7.3.3 INDUSTRIAL ENZYMES 78
7.4 FOOD AND AGRICULTURE 79
7.5 ENVIRONMENTAL APPLICATIONS 81
7.5.1 BIOREMEDIATION 83
7.5.2 BIOSENSING 84

8 SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY 85
8.1 INTRODUCTION 86
8.2 NORTH AMERICA 88
8.2.1 US 93
8.2.2 CANADA 98
8.3 EUROPE 102
8.3.1 UK 107
8.3.2 GERMANY 111
8.3.3 FRANCE 115
8.3.4 DENMARK 119
8.3.5 SWITZERLAND 123
8.3.6 REST OF EUROPE (ROE) 126
8.4 ASIA PACIFIC 130
8.4.1 JAPAN 133
8.4.2 CHINA 137
8.4.3 AUSTRALIA 141
8.4.4 REST OF ASIA PACIFIC (ROAPAC) 144
8.5 REST OF THE WORLD (ROW) 148
8.5.1 LATIN AMERICA 152
8.5.2 MIDDLE EAST AND AFRICA 155
9 COMPETITIVE LANDSCAPE 160
9.1 OVERVIEW 160
9.2 MARKET SHARE ANALYSIS, 2016 161
9.3 COMPETITIVE SCENARIO 162
9.3.1 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 162
9.3.2 EXPANSIONS 163
9.3.3 PRODUCT LAUNCHES 163
9.3.4 ACQUISITIONS 164
9.3.5 OTHER DEVELOPMENTS 164
10 COMPANY PROFILES 165
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
10.1 THERMO FISHER SCIENTIFIC 165
10.2 NOVOZYMES 170
10.3 MERCK KGAA 174
10.4 INTREXON CORPORATION 178
10.5 AGILENT TECHNOLOGIES 182
10.6 AMYRIS 186
10.7 GENSCRIPT BIOTECH CORPORATION 189
10.8 GINKGO BIOWORKS 192
10.9 INTEGRATED DNA TECHNOLOGIES (IDT) 194
10.10 NEW ENGLAND BIOLABS (NEB) 197
10.11 SYNTHETIC GENOMICS 199
10.12 TWIST BIOSCIENCE 202
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX 205
11.1 INSIGHTS OF INDUSTRY EXPERTS 205
11.2 DISCUSSION GUIDE 206
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 209
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 211
11.5 RELATED REPORTS 213
11.6 AUTHOR DETAILS 214

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+